Skip to content

kinesiotape in patients with Multiple myelosis

Effects of kinesiotape on pain, range of motion, and functional status in patients with relapsing remitting Multiple Sclerosis: a randomized clinical trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240316061307N1
Enrollment
12
Registered
2024-04-20
Start date
2024-03-20
Completion date
Unknown
Last updated
2024-05-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple sclerosis. Multiple sclerosis

Interventions

Intervention 1: In the KT intervention group, according to the method proposed by the International Association of Kinesiotaping (kinesiotaping.com), it is closed using a restraining method (from inse

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 50 Years

Inclusion criteria

Inclusion criteria: Definitive diagnosis of relapsing remitting MS with mild to moderate severity (EDSS less than 4.5) Ability to walk at least 500 meters without using aids Complaints of lower limb spasms

Exclusion criteria

Exclusion criteria: Taking muscle relaxants such as tizanidine, baclofen, methocarbamol Not agreeing to participate or continue the participation Participating in a rehabilitation program or sports activity in the past month Presence of another musculoskeletal disease that affects the patient's lower limbs Presence of kinesiotape contraindications such as: deep vein thrombosis, kidney failure, congestive heart disease, infection, wound, cancer and sensitivity to kinesiotape. History of MS attack in the past month

Design outcomes

Primary

MeasureTime frame
In this study, the primary outcome is muscle spasticity,. Timepoint: In both groups, the following evaluations are performed before the intervention, immediately after the intervention and after opening the bandage (48 hours after the intervention). Method of measurement: It is measured by the Modified Ashworth Scale (MAS). MAS is a scale for measuring muscle tone and is completed by the therapist who passively stretches the desired muscle group and scores the movement resistance between 0 and 5. which is rated as follows: 0: no increase in muscle tone; 1: A slight increase in muscle tone so that it appears with a slight cramp and release or a small resistance at the end of ROM. 1+: slight increase in muscle tone so that it appears with slight cramping or little resistance at the beginning or half of the ROM. 2: Significant increase in muscle tone in the majority of ROM so that the involved limb can be easily moved; 3: significant increase in muscle tone, but passive movement of the involved limb is difficult; and 4: the affected organ is rigid. This questionnaire was translated into Farsi in 2012 by Ansari et al. and its validity and reliability were evaluated. Another scale called Numeric Rating of Spasm or NRS is used to evaluate muscle spasm. To use this scale, the patient is asked to score his perception of spasm from 0 to 10.;In this study, the primary outcome is the patient's muscle function. Timepoint: In both groups, the following evaluations are performed before the intervention, immediately after the intervention and after opening the bandage (48 hours after the intervention). Method of measurement: Timed up and go test (TUG) is used to evaluate patients' performance. In the Timed up and go test (TUG), the patient sits on a chair, when the test starts, the patient must get up from the chair, walk a distance of 3 meters and return to the chair and sit again. The test time is recorded in seconds. Another tool that is used to evaluate the performance of pati

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMaryam Najafi

Tehran University of Medical Sciences

m_najafi@razi.tums.ac.ir+98 21 6634 8500

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026